Study of BGG492 in Patients With Chronic Subjective Tinnitus

Status:
Completed

Trial end date:
2012-01-01

Target enrollment:

Participant gender:

This study will assess the efficacy of a two week treatment with BGG492 in patients with chronic subjective Tinnitus.

Phase 2

Novartis Pharmaceuticals